Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Simulations Plus Inc (NASDAQ:SLP)

6.94
Delayed Data
As of 1:22pm ET
 +0.2299 / +3.43%
Today’s Change
5.52
Today|||52-Week Range
7.15
+3.89%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Packaged Software
MARKET CAP
$113.3M

Company Description

Simulations Plus, Inc. develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. It engages in the drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. The company also provides personal productivity software program called Abbreviate. Simulations Plus was founded by Walter S. Woltosz & Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Contact Information

Simulations Plus, Inc.
42505 10th Street West
Lancaster California 93534-7059
P:(661) 723-7723
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Walter S. WoltoszChairman & Chief Executive Officer
Thaddeus Henry GraselaPresident & Director
John R. KneiselChief Financial Officer
Michael B. BolgerChief Scientific Officer
Robert D. ClarkCheminformatics Director